157 related articles for article (PubMed ID: 35075959)
1. Cutaneous and splenic mastocytosis in a juvenile Malayan tiger.
Smedley RC; Stedman NL; Kiupel M
J Vet Diagn Invest; 2022 Mar; 34(2):288-291. PubMed ID: 35075959
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of feline mast cell tumors.
Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
[TBL] [Abstract][Full Text] [Related]
3. Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat.
Lamm CG; Stern AW; Smith AJ; Cooper EJ; Ullom SW; Campbell GA
J Vet Diagn Invest; 2009 Sep; 21(5):710-5. PubMed ID: 19737771
[TBL] [Abstract][Full Text] [Related]
4. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
5. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours.
Sabattini S; Barzon G; Giantin M; Lopparelli RM; Dacasto M; Prata D; Bettini G
Vet Comp Oncol; 2017 Sep; 15(3):1051-1061. PubMed ID: 27278268
[TBL] [Abstract][Full Text] [Related]
6. Expression of KIT receptor in feline cutaneous mast cell tumors.
Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
Isotani M; Yamada O; Lachowicz JL; Tamura K; Yagihara H; Fujino Y; Ono K; Washizu T; Bonkobara M
Br J Haematol; 2010 Jan; 148(1):144-53. PubMed ID: 19804453
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
9. Management of a neonate with diffuse cutaneous mastocytosis: Case report and literature review.
Jenkinson HA; Lundgren AD; Carter MC; Diaz LZ; Levy ML
Pediatr Dermatol; 2019 Jul; 36(4):486-489. PubMed ID: 30828864
[TBL] [Abstract][Full Text] [Related]
10. Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment.
Zmorzynski S; Kimicka-Szajwaj A; Szajwaj A; Czerwik-Marcinkowska J; Wojcierowski J
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275618
[TBL] [Abstract][Full Text] [Related]
11. Activating mutations in the catalytic or juxtamembrane domain of c-kit in splenic mast cell tumors of cats.
Dank G; Chien MB; London CA
Am J Vet Res; 2002 Aug; 63(8):1129-33. PubMed ID: 12171166
[TBL] [Abstract][Full Text] [Related]
12. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
[TBL] [Abstract][Full Text] [Related]
13. Mutation and methylation status of KIT and TP
Vozdova M; Kubickova S; Fictum P; Cernohorska H; Fröhlich J; Rubes J
Vet Comp Oncol; 2020 Sep; 18(3):438-444. PubMed ID: 31574575
[TBL] [Abstract][Full Text] [Related]
14. KIT mutations in mast cell tumours from cheetahs (Acinonyx jubatus) and domestic cats (Felis catus).
Tamlin VS; Bottema CDK; Campbell-Ward ML; Hanshaw D; Peaston AE
Vet Comp Oncol; 2021 Jun; 19(2):381-392. PubMed ID: 33506612
[TBL] [Abstract][Full Text] [Related]
15. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
Longley BJ; Tyrrell L; Lu SZ; Ma YS; Langley K; Ding TG; Duffy T; Jacobs P; Tang LH; Modlin I
Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral heterogeneity of c-KIT mutations in a feline splenic mast cell tumor and their functional effects on cell proliferation.
Hasegawa Y; Shosu K; Tsuji K; Shimoyama Y; Miyama TS; Baba K; Okuda M; Itamoto K; Igase M; Mizuno T
Sci Rep; 2022 Sep; 12(1):15791. PubMed ID: 36138037
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
[TBL] [Abstract][Full Text] [Related]
19. The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs.
Gentilini F; Turba ME; Dally C; Takanosu M; Kurita S; Bonkobara M
BMC Vet Res; 2020 Feb; 16(1):64. PubMed ID: 32075643
[TBL] [Abstract][Full Text] [Related]
20. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate.
Isotani M; Tamura K; Yagihara H; Hikosaka M; Ono K; Washizu T; Bonkobara M
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):168-72. PubMed ID: 16908071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
